At the beginning of 2023, the state's health plan covered 5,000 prescriptions for GLP-1 drugs, but that number skyrocketed to nearly 25,000 by the end of 2023
Why it was included in the FDA ban Melanotan II was banned for reported adverse effects like melanoma skin cancers, posterior reversible encephalopathy syndrome (a seizure and headache disorder), sympathomimetic toxidrome (symptoms of poisoning), and priapism (dangerous, prolonged erections)
Comparing GLP-1 before and after results: semaglutide vs tirzepatide Not all GLP-1 medications produce identical before and after results
A patient describing constant, dull aching in multiple muscle groups may have medication-related myalgia, caloric-deficit-related soreness, or early hypothyroidism rather than true cramping
The vitamin C interaction profile changes significantly for systemic peptide use
Whether it be Milwaukee, Madison, Green Bay, or Kenosha businesses in Wisconsin can receive our products in the shortest turnaround times